BioCentury | Feb 18, 2013
Clinical News

All-In-One: Clinical trial started

...Minn.) markets Resolute Integrity, a zotarolimus-eluting coronary stent utilizing the BioLinx polymer, to treat CAD. Svelte Medical Systems Inc....
BioCentury | Nov 14, 2011
Clinical News

All-In-One update

...Svelte began the DIRECT trial to evaluate its All-In-One stent system in 30 patients. Svelte Medical Systems Inc....
BioCentury | Nov 14, 2011
Company News

Svelte Medical Systems, Royal DSM deal

...is in a first-in-man clinical trial to treat coronary artery lesions. Details were not disclosed. Svelte Medical Systems Inc....
Items per page:
1 - 3 of 3
BioCentury | Feb 18, 2013
Clinical News

All-In-One: Clinical trial started

...Minn.) markets Resolute Integrity, a zotarolimus-eluting coronary stent utilizing the BioLinx polymer, to treat CAD. Svelte Medical Systems Inc....
BioCentury | Nov 14, 2011
Clinical News

All-In-One update

...Svelte began the DIRECT trial to evaluate its All-In-One stent system in 30 patients. Svelte Medical Systems Inc....
BioCentury | Nov 14, 2011
Company News

Svelte Medical Systems, Royal DSM deal

...is in a first-in-man clinical trial to treat coronary artery lesions. Details were not disclosed. Svelte Medical Systems Inc....
Items per page:
1 - 3 of 3